212 related articles for article (PubMed ID: 2062601)
1. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population.
Santosham M; Hill J; Wolff M; Reid R; Lukacs L; Ahonkhai V
Pediatr Infect Dis J; 1991 Feb; 10(2):113-7. PubMed ID: 2062601
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children.
Santosham M; Rivin B; Wolff M; Reid R; Newcomer W; Letson GW; Almeido-Hill J; Thompson C; Siber GR
J Infect Dis; 1992 Jun; 165 Suppl 1():S144-51. PubMed ID: 1588150
[TBL] [Abstract][Full Text] [Related]
3. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
[TBL] [Abstract][Full Text] [Related]
4. Antibody response of Navajo children primed with PRP-OMP vaccine to booster doses of PRP-OMP vs. HbOC vaccine.
Reid R; Santosham M; Croll J; Thompson C; Newcomer W; Siber GR
Pediatr Infect Dis J; 1993 Oct; 12(10):812-5. PubMed ID: 8284116
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants.
Bulkow LR; Wainwright RB; Letson GW; Chang SJ; Ward JI
Pediatr Infect Dis J; 1993 Jun; 12(6):484-92. PubMed ID: 8345981
[TBL] [Abstract][Full Text] [Related]
6. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Anderson EL; Osterholm MT; Holmes SJ; McHugh JE; Belshe RB; Medley F; Murphy TV
J Pediatr; 1992 Aug; 121(2):187-94. PubMed ID: 1640282
[TBL] [Abstract][Full Text] [Related]
7. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
[TBL] [Abstract][Full Text] [Related]
8. The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.
Capeding MR; Nohynek H; Pascual LG; Kayhty H; Sombrero LT; Eskola J; Ruutu P
Am J Trop Med Hyg; 1996 Nov; 55(5):516-20. PubMed ID: 8940983
[TBL] [Abstract][Full Text] [Related]
9. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children.
Harrison LH; Tajkowski C; Croll J; Reid R; Hu D; Brenneman G; Weatherholtz RC; Santosham M
J Pediatr; 1994 Oct; 125(4):571-6. PubMed ID: 7931875
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
Walter EB; Moggio MV; Drucker RP; Wilfert CM
Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with PedvaxHIB, a conjugate vaccine of Haemophilus influenzae type b polysaccharide--Neisseria meningitidis outer membrane protein.
Ahonkhai VI; Lukacs LJ; Jonas LC; Calandra GB
Vaccine; 1991 Jun; 9 Suppl():S38-41; discussion S42-3. PubMed ID: 1891956
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and reactogenicity of Haemophilus influenzae type b-meningococcus group B outer membrane protein conjugate vaccine in children 2-60 months of age.
Shehab ZM; Azimi P; Asmar BI; Dunphy MG; Ayoub EM; Dajani AS
Scand J Infect Dis; 1991; 23(6):763-9. PubMed ID: 1815340
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
[TBL] [Abstract][Full Text] [Related]
15. Response of 7- to 15-month-old infants to sequential immunization with Haemophilus influenzae type b-CRM197 conjugate and polysaccharide vaccines.
Rothstein EP; Schiller RP; Girone JA; Hipp TJ; Souder RL; Bernstein HH; Madore DV; Johnson CL; Smith DH
Am J Dis Child; 1991 Aug; 145(8):898-900. PubMed ID: 1858727
[TBL] [Abstract][Full Text] [Related]
16. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
[TBL] [Abstract][Full Text] [Related]
18. Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants.
Santosham M; Englund JA; McInnes P; Croll J; Thompson CM; Croll L; Glezen WP; Siber GR
Pediatr Infect Dis J; 2001 Oct; 20(10):931-40. PubMed ID: 11642626
[TBL] [Abstract][Full Text] [Related]
19. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines.
Decker MD; Edwards KM; Bradley R; Palmer P
J Pediatr; 1992 Feb; 120(2 Pt 1):184-9. PubMed ID: 1735812
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]